More than one-third of patients undergoing catheter-directed thrombolysis of deep vein thrombosis receive an inferior vena cava (IVC) filter, yet placement of the device is not associated with a ...
Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...
New York, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia-Pacific Clot Management Devices Market Outlook to 2025 - CDT Catheters, Embolectomy Balloon ...
The FDA cleared BiO2 Medical’s catheter for the protection of critically ill patients from pulmonary embolism. It is the first venous catheter to be approved for prophylactic use in addition to ...
Peripherally inserted central catheter tip position and risk of associated complications in neonates
This was a retrospective cohort study of infants admitted between July 2006 and December 2009 at a tertiary neonatal intensive care unit, Mount Sinai Hospital, Toronto. PICCs’ were inserted either by ...
Catheter-associated thrombosis is the most common noninfectious complication of implantable venous access devices and can cause superior vena cava syndrome. The diagnosis can be confirmed with Doppler ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD is produced by the Cardiovascular Research Foundation (CRF). CRF is committed to igniting the ...
The gold standard of vascular access for chronic hemodialysis patients is the arteriovenous fistula (AVF). If an AVF cannot be created, the hemodialysis catheter can be inserted into the internal ...
SAN ANTONIO, March 11, 2013 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback